Indispensability of Clinical Bioinformatics for Effective Implementation of Genomic Medicine in Pathology Laboratories

ACI open Pub Date : 2020-07-01 DOI:10.1055/s-0040-1721480
S. Chamala, S. Majety, Sheshnath Mishra, Kimberly J. Newsom, Shaileshbhai R. Gothi, Nephi A. Walton, R. Dolin, P. Starostik
{"title":"Indispensability of Clinical Bioinformatics for Effective Implementation of Genomic Medicine in Pathology Laboratories","authors":"S. Chamala, S. Majety, Sheshnath Mishra, Kimberly J. Newsom, Shaileshbhai R. Gothi, Nephi A. Walton, R. Dolin, P. Starostik","doi":"10.1055/s-0040-1721480","DOIUrl":null,"url":null,"abstract":"Abstract Patient care is rapidly evolving toward the inclusion of precision genomic medicine when genomic tests are used by clinicians to determine disease predisposition, prognosis, diagnosis, and improve therapeutic decision-making. However, unlike other clinical pathology laboratory tests, the development, deployment, and delivery of genomic tests and results are an intricate process. Genomic technologies are diverse, fast changing, and generate massive data. Implementation of these technologies in a Clinical Laboratory Improvement Amendments-certified and College of American Pathologists-accredited pathology laboratory often require custom clinical grade computational data analysis and management workflows. Additionally, accurate classification and reporting of clinically actionable genetic mutation requires well-curated disease/application-specific knowledgebases and expertise. Moreover, lack of “out of the box” technical features in electronic health record systems necessitates custom solutions for communicating genetic information to clinicians and patients. Genomic data generated as part of clinical care easily adds great value for translational research. In this article, we discuss current and future innovative clinical bioinformatics solutions and workflows developed at our institution for effective implementation of precision genomic medicine across molecular pathology, patient care, and translational genomic research.","PeriodicalId":72041,"journal":{"name":"ACI open","volume":"04 1","pages":"e167 - e172"},"PeriodicalIF":0.0000,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-0040-1721480","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACI open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0040-1721480","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Abstract Patient care is rapidly evolving toward the inclusion of precision genomic medicine when genomic tests are used by clinicians to determine disease predisposition, prognosis, diagnosis, and improve therapeutic decision-making. However, unlike other clinical pathology laboratory tests, the development, deployment, and delivery of genomic tests and results are an intricate process. Genomic technologies are diverse, fast changing, and generate massive data. Implementation of these technologies in a Clinical Laboratory Improvement Amendments-certified and College of American Pathologists-accredited pathology laboratory often require custom clinical grade computational data analysis and management workflows. Additionally, accurate classification and reporting of clinically actionable genetic mutation requires well-curated disease/application-specific knowledgebases and expertise. Moreover, lack of “out of the box” technical features in electronic health record systems necessitates custom solutions for communicating genetic information to clinicians and patients. Genomic data generated as part of clinical care easily adds great value for translational research. In this article, we discuss current and future innovative clinical bioinformatics solutions and workflows developed at our institution for effective implementation of precision genomic medicine across molecular pathology, patient care, and translational genomic research.
临床生物信息学对病理学实验室有效实施基因组医学的必要性
摘要当临床医生使用基因组测试来确定疾病易感性、预后、诊断和改善治疗决策时,患者护理正在迅速向纳入精确基因组医学的方向发展。然而,与其他临床病理学实验室测试不同,基因组测试和结果的开发、部署和交付是一个复杂的过程。基因组技术多种多样,变化迅速,并产生大量数据。在临床实验室改进修正案认证和美国病理学家学院认证的病理学实验室中实施这些技术通常需要定制临床级计算数据分析和管理工作流程。此外,临床可操作基因突变的准确分类和报告需要精心策划的疾病/应用特定知识库和专业知识。此外,电子健康记录系统缺乏“开箱即用”的技术功能,需要定制解决方案来向临床医生和患者传达基因信息。作为临床护理的一部分生成的基因组数据很容易为转化研究增加巨大价值。在这篇文章中,我们讨论了我们机构为在分子病理学、患者护理和转化基因组研究中有效实施精确基因组医学而开发的当前和未来创新的临床生物信息学解决方案和工作流程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书